Phenotype measures associated with
VT:0010439   'response to viral infection trait'


Select table page: First Prev Next Last
   FILTER RESULTS BY:
Data set Clear All
Procedure / Protocol Clear All
Drug or Challenge Clear All
Panel Clear All
Sex Clear All
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Boon1 46911 body weight influenza A (H5N1) virus change in body weight, post-infection   [%]     dosage group:    low    medium    high inbred 18 f 6-9wks N=11 2011
    Boon1 46921 health assessment influenza A (H5N1) virus survival (days to death, max 30)   [d]     dosage group:    low    medium    high inbred 18 f 6-9wks N=11 2011
    Boon1 46931 health assessment influenza A (H5N1) virus susceptibility to viral infection (0=susceptible, 1=resistant)   [designation]     dosage group:    low    medium    high inbred 18 f 6-9wks N=11 2011
    Ferris1 47603 health assessment influenza A (H1N1) virus clinical score, day 4 post-infection (score 0-4)   [score]  clinical_score CC pre w/par 161 f 8-16wks N=1 2012
    Ferris1 47605 health assessment influenza A (H1N1) virus susceptibility to viral infection index (0=susceptible; 1= resistant)   [score]  susceptibility_index CC pre w/par 161 f 8-16wks N=1 2012
    Ferris1 47606 in vitro assay influenza A (H1N1) virus viral replication log titer, day 4 post-infection (lung)   [n]  titer CC pre w/par 162 f 8-16wks N=1 2012
    Ferris1 47607 histopathology influenza A (H1N1) virus virus-induced airway inflammation, day 4 post-infection (score 0-3)   [score]  airway_inflam CC pre w/par 161 f 8-16wks N=1 2012
    Ferris1 47608 histopathology influenza A (H1N1) virus virus-induced airway neutrophils, day 4 post-infection (score 0-3)   [score]  airway_neut CC pre w/par 140 f 8-16wks N=1 2012
    Ferris1 47609 histopathology influenza A (H1N1) virus virus-induced airway damage, day 4 post-infection (score 0-3)   [score]  airway_damage CC pre w/par 160 f 8-16wks N=1 2012
    Ferris1 47610 histopathology influenza A (H1N1) virus virus-induced vascular inflammation (lung), day 4 post-infection (score 0-3)   [score]  vascular_inflam CC pre w/par 161 f 8-16wks N=1 2012
    Ferris1 47611 histopathology influenza A (H1N1) virus virus-induced alveolar inflammation, day 4 post-infection (score 0-3)   [score]  alveolar_inflam CC pre w/par 161 f 8-16wks N=1 2012
    Ferris1 47612 histopathology influenza A (H1N1) virus virus-induced alveolar damage, day 4 post-infection (score 0-3)   [score]  alveolar_damage CC pre w/par 161 f 8-16wks N=1 2012
    Ferris1 47613 histopathology influenza A (H1N1) virus virus-induced pulmonary edema, day 4 post-infection (score 0-3)   [score]  pulmonary_edema CC pre w/par 138 f 8-16wks N=1 2012
Rodriguez1 24101 in vitro assay (none) spleen and liver murine cytomegalovirus genome levels   [PFU]  CMV_LEVELS QTL population both 8-12wks N=92 2009
    Schughart1 39305 health assessment influenza A (H1N1) virus susceptibility to viral infection (0=susceptible; 1=resistant)   [designation]  susceptibility inbred 9 both 10-12wks N=11 2009
    Schughart2 49606 health assessment influenza A (H1N1) virus survival, post-infection (in days)   [d]  survival_days BXD w/par 56 f 9-18wks N=6 2012
    Schughart2 49607 health assessment influenza A (H1N1) virus susceptibility to viral infection (0=susceptible; 1=resistant)   [designation]  susceptibility BXD w/par 56 f 9-18wks N=6 2012
    Schughart3 57111 body weight influenza A (H3N2) virus body weight as percent of baseline, 10 FFU group   [%]     days post-infection:    1    2    3    4    5    6    7    8    9    10    11    12    13    14 inbred w/CC8 8 both 7-13wks N=9 2013
    Schughart3 57131 body weight influenza A (H3N2) virus body weight as percent of baseline, 2000 FFU group   [%]     days post-infection:    1    2    3    4    5    6    7    8    9    10    11    12    13    14 inbred w/CC8 8 both 7-13wks N=9 2013
    Schughart3 57151 body weight influenza A (H3N2) virus body weight as percent of baseline, 200,000 FFU group   [%]     days post-infection:    1    2    3    4    5    6    7    8    9    10    11    12    13    14 inbred 2 both 7-13wks N=12 2013
    Schughart3 57181 health assessment influenza A (H3N2) virus survival, post-infection   [d]     10 FFU group    2000 FFU group    200000 FFU group inbred w/CC8 8 both 7-13wks N=11 2013
    Schughart3 57191 health assessment influenza A (H3N2) virus susceptibility to viral infection (0=resistant, 1=susceptible), mortality rate   [score]     10 FFU group    2000 FFU group    200000 FFU group inbred w/CC8 8 both 7-13wks N=11 2013
    Schughart4 58711 body weight (none) body weight as percent of baseline, control (saline) group   [%]     days post-treatment (saline):    1    2    3 inbred w/CC8 8 f 8-12wks N=6 2016
    Schughart4 58721 body weight influenza A (H3N2) virus body weight as percent of baseline, infected group   [%]     days post-infection:    1    2    3    4    5    6    7    8    9    10    11    12    13    14    18    30 inbred w/CC8 8 f 8-12wks N=11 2016
    Schughart4 58741 complete blood count influenza A (H3N2) virus white blood cell count (WBC; per volume x 103), control group, day 3   [n/µL]  WBC_ctrl_d3 inbred w/CC8 8 f 8-12wks N=5 2016
    Schughart4 58743 complete blood count influenza A (H3N2) virus white blood cell count (WBC), treated group   [n/µL]     days post-infection:    3    5    8    18    30 inbred w/CC8 8 f 8-12wks N=6 2016
    Schughart4 58751 complete blood count influenza A (H3N2) virus lymphocyte differential (percent of total WBC), control group, day 3   [%]  pctLYM_ctrl_d3 inbred w/CC8 8 f 8-12wks N=5 2016
    Schughart4 58753 complete blood count influenza A (H3N2) virus lymphocyte differential, treated group   [%]     days post-infection:    3    5    8    18    30 inbred w/CC8 8 f 8-12wks N=6 2016
    Schughart4 58761 complete blood count influenza A (H3N2) virus monocyte differential (percent of total WBC), control group, day 3   [%]  pctMONO_ctrl_d3 inbred w/CC8 8 f 8-12wks N=5 2016
    Schughart4 58763 complete blood count influenza A (H3N2) virus monocyte differential, treated group   [%]     days post-infection:    3    5    8    18    30 inbred w/CC8 8 f 8-12wks N=6 2016
    Schughart4 58771 complete blood count influenza A (H3N2) virus granulocyte differential (percent of total WBC), control group, day 3   [%]  pctGRA_ctrl_d3 inbred w/CC8 8 f 8-12wks N=5 2016
    Schughart4 58773 complete blood count influenza A (H3N2) virus granulocyte differential, treated group   [%]     days post-infection:    3    5    8    18    30 inbred w/CC8 8 f 8-12wks N=6 2016
    Schughart4 58783 in vitro assay influenza A (H3N2) virus viral load in lungs (titer, FFU per lung) log10 (x+1)   [log(n)]     days post-infection:    3    5    8 inbred w/CC8 8 f 8-12wks N=5 2016
    Schughart5 58811 body weight (none) body weight as percent of baseline   [%]     days post-treatment (saline):    1    2    3 inbred w/CC8 8 f 8-12wks N=4 2016
    Schughart5 58821 body weight influenza A (H3N2) virus body weight as percent of baseline, 10 FFU group   [%]     days post-infection:    1    2    3    4    5    6    7    8    9    10    11    12    13    14    18    30 inbred w/CC8 8 f 8-12wks N=9 2016
    All boxes             To see more rows use the paging control at top.